Craniofacial fibrous dysplasia: a challenge for general dental practitioners
OPEN | VERIFIABLE CPD PAPER
Restorative Dentistry
CLINICAL
Craniofacial fibrous dysplasia: a challenge for general
dental practitioners
Manuel W. H. Man,*1 Roshni Ruparelia,2 Jasleen K. Batra,3 Krupti Denhard4 and Ulpee R. Darbar4
Key points
Early recognition of the oral and dental features
of fibrous dysplasia is important to initiate early
management.
General dental practitioners play an essential role in
the early recognition of these features.
Patients with craniofacial fibrous dysplasia have
complex integrated treatment needs which need
early recognition, intervention and referral if
necessary.
Abstract
Craniofacial fibrous dysplasia (CFD) is an asymptomatic disease that can have oral manifestations with severe effects
on a patient’s wellbeing. It is usually diagnosed based on patient concerns, including poor appearance due to
spacing and functional difficulties in eating and speaking, as well as the presenting features, such as facial asymmetry
and corresponding malocclusion, delayed or abnormal tooth eruption, and painless swelling or bony expansion.
General dental practitioners (GDPs) will often see patients presenting with these multiple symptoms which can be
overwhelming. An awareness of the oral and dental features is thus important to make an early diagnosis and to
ensure that the patient is given the best advice and guidance early on what is available to address their concerns.
This paper provides an overview of the oral and dental features associated with CFD and presents two cases in whom
delayed diagnosis resulted in complex treatment needs to address their concerns. Both cases highlight the importance
of early diagnosis and the essential role of GDPs in early recognition of the condition to optimise patient care and
wellbeing.
Introduction
Fibrous dysplasia (FD) is a rare, developmental,
benign fibro-osseous disease in which normal
bone is replaced with fibrous tissue and
structurally weak bone due to a change in
normal bone metabolism by somatic gene
mutation during embryogenesis.1 The clinical
symptoms of the disease depend on when the
mutation occurs and the level of differentiation
of the primary pluripotent cells.2 Its incidence
is estimated to be 1-in-5,000–10,0003 and
constitutes 5–7% of all benign bone lesions.4,5
Specialty Doctor in Restorative Dentistry, Royal National
ENT & Eastman Dental Hospital, 47–49 Huntley Street,
London, WC1E 6DG, UK; 2Dental Core Trainee 2 in
Restorative Dentistry, Royal National ENT & Eastman
Dental Hospital, 47–49 Huntley Street, London, WC1E 6DG,
UK; 3Dental Core Trainee 1 in Restorative Dentistry, Royal
National ENT & Eastman Dental Hospital, 47–49 Huntley
Street, London, WC1E 6DG, UK; 4Consultant in Restorative
Dentistry, Royal National ENT & Eastman Dental Hospital,
47–49 Huntley Street, London, WC1E 6DG, UK.
*Correspondence to: Manuel W. H. Man
Email address:
1
Refereed Paper.
Submitted 13 June 2024
Revised 26 June 2025
Accepted 1 July 2025
https://doi.org/10.1038/s41415-025-9010-y
A 2:1 female-to-male ratio has been suggested
with manifestation usually in the first few
years of life.6
FD can be monostotic involving one
bone, polyostotic involving multiple bones,
or syndromic being associated with JaffeLichtenstein disease, or Mazabraud and
McCune-Albright syndromes.7 Those with
the McCune-Albright syndrome also present
with skin pigmentation, with light brown
irregularly shaped patches with jagged edges
known as ‘café-au-lait spots’. Other features
related to endocrine abnormalities include
hyperthyroidism, excess cortisol production
(Cushing’s syndrome), enlarged facial features,
hands and feet (acromegaly)8 and proptosis
(bulging eyes). Hearing loss or optic nerve
damage caused by cranial nerve compression
may also be seen.9 Monostotic FD accounts for
70% of all cases and involves the jaw bones,
especially the posterior maxilla, in which
painless expansion of the bone occurs, with
the term craniofacial fibrous dysplasia (CFD)
used to describe cranial bone involvement.5
Its prevalence in the craniofacial region
ranges from 10–25% in monostotic disease,
and up to 90% in polyostotic disease.10,11 The
clinical features of FD are influenced by the
BRITISH DENTAL JOURNAL | VOLUME 239 NO. 10 | November 28 2025
© The Author(s) 2025.
type and can be isolated to small areas or may
involve extensive spread to wider areas. CFD
lesions are some of the earliest that can be
detected, and the maxilla is affected almost
twice as often as the mandible, with the
lesions usually expanding during childhood/
adolescence and becoming less active in
adulthood. Expansion of the alveolar ridge
cortices may extend to the hard palate.12,13
Other facial and dental features include facial
asymmetry and deformity caused by the bone
expansion within the jaw; malocclusion; tooth
displacement; dental crowding and spacing;
enamel hypoplasia; odontomas and retained
primary teeth; diminution of the maxillary
sinus; dentine dysplasia; and taurodont pulp
chambers.14 Patients with CFD may also have
a high caries incidence and when present with
jaw deformities and café-au-lait lesions, a
diagnosis of CFD should be suspected.
Diagnosis of CFD is based on the patient’s
history and clinical presentation; however,
radiographic findings can be variable
depending on the extent and severity of the
disease. The classical radiographic appearance
of the bone is described as ‘ground-glass’ or
‘mixed mottled’ with interspersed radiolucency
and radiopacity and ill-defined lamina dura.15
693
CLINICAL
Restorative Dentistry
Table 1 Differential diagnosis of craniofacial fibrous dysplasia (CFD)
Differential diagnosis
Clinical presentation
Radiographic appearance
Similarity with CFD
Difference with CFD
Simple bone cyst41
Usually asymptomatic and found
incidentally
Can cause pain or swelling if it expands
Well-defined, radiolucent,
solitary lesion with smooth
borders and no cortical
destruction
Painless swellings
Often discovered incidentally
Radiolucent with no
internal radiopacities
Ossifying fibroma
Well-defined and slow-growing benign
tumour
Expansile lesion with a clearer
cortical boundary
Painless bony expansion
Mixed radiolucent-radiopaque
appearance with cortical
thinning and expansion
Well-demarcated and
encapsulated
Osseous dysplasia43
Non-expansile growth pattern
Usually asymptomatic
Radiolucent in early stage which
tends to become mixed and
eventually radiopaque as it
matures
Asymptomatic
Often discovered incidentally
Ground-glass radiographic
appearance
Non-expansile
Usually no facial
asymmetry
Giant cell tumour44
Painful, rapidly-enlarging mass
May cause pathological fracture
Purely radiolucency
Well-defined lesion
Cortical thinning and possible
expansion
Facial swelling
Radiographically expansile with
cortical thinning
Painful, rapidly expanding
Radiographically
purely radiolucent and
multilocular
Aneurysmal bone cyst45
Painful and rapidly growing swelling
May cause pathological fracture and
tenderness
Mul (...truncated)